| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/10/2003 | CN1441800A Beta 3 adrenergic agonists |
| 09/10/2003 | CN1441799A New thiochromane derivatives and use as thrombin inhibitors |
| 09/10/2003 | CN1441798A Thiophene vitamine A |
| 09/10/2003 | CN1441796A Cyclic substituted aminomethyl compounds and medicaments containing said compounds |
| 09/10/2003 | CN1441795A Method for preparation of citalopram |
| 09/10/2003 | CN1441794A Lipid-rich plague inhibitors |
| 09/10/2003 | CN1441793A Tocotrienolquinone cyclisation product with anti-hypercholesterol effect |
| 09/10/2003 | CN1441791A 四唑衍生物 Tetrazole derivative |
| 09/10/2003 | CN1441789A Piperazinedione compounds |
| 09/10/2003 | CN1441788A Novel arylethene-sulfonamides compounds |
| 09/10/2003 | CN1441787A Modulators of TNF-alpha signaling |
| 09/10/2003 | CN1441785A Tetrahydroixoquinoline analogs useful as growth hormone secretagogues |
| 09/10/2003 | CN1441784A Thrombin inhibitors comprising aminoisoquinoline group |
| 09/10/2003 | CN1441783A Medicine comprising dicyanopyridine derivative |
| 09/10/2003 | CN1441782A N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
| 09/10/2003 | CN1441781A Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity |
| 09/10/2003 | CN1441780A Piperidine compounds for use as CCR-3 inhibitors |
| 09/10/2003 | CN1441778A Pleuromutilin derivatives having antibacterial activity |
| 09/10/2003 | CN1441777A Inhibiting angiogenesis and tumor growth |
| 09/10/2003 | CN1441776A Novel aryl, alkenyl and alkynl 4-dedimethylamino tetracycline derivatives |
| 09/10/2003 | CN1441775A Hiv整合酶抑制剂 Hiv integrase inhibitors |
| 09/10/2003 | CN1441773A Cyclohexylamine derivative as subtype selective NMDA receptor Antagonists |
| 09/10/2003 | CN1441770A Modified forms of pharmacologically active agents and uses therefor |
| 09/10/2003 | CN1441704A Medium milling |
| 09/10/2003 | CN1441679A Compositions containing therapentically active components having enhanced solubility |
| 09/10/2003 | CN1441677A Combined use of anti-cytokine antibodies or antagonists and anti-CD2O for treatment of B cell lymphoma |
| 09/10/2003 | CN1441674A Diphosphonate solutions |
| 09/10/2003 | CN1441673A 4,5-dihydro-thiazo-2-ylamine derivatives and their use as NO-synthase inhibitors |
| 09/10/2003 | CN1441672A Methods for treatment of inflammatory diseases |
| 09/10/2003 | CN1441671A Fatty acid analogues for treatment of cancer |
| 09/10/2003 | CN1441670A Highly efficient delivery of large therapeutic mass aerosol |
| 09/10/2003 | CN1441669A Method for formulating healthcare products with enhanced stability |
| 09/10/2003 | CN1441668A Compositions and methods to improve oral absorption of antimicrobial agents |
| 09/10/2003 | CN1441667A Pharmaceutical compositions |
| 09/10/2003 | CN1441664A Synergistic antiplaque/antigivitis oral composition |
| 09/10/2003 | CN1441638A Parasiticide and parasitic method for globefish |
| 09/10/2003 | CN1440984A Dauricine polysaccharide, its extraction method and the use of medicine with the compound as active component |
| 09/10/2003 | CN1440979A Steroid saponin from sealwort as Chinese medicine material and its medicinal use and prepn process |
| 09/10/2003 | CN1440978A Pyloric spirobacterium inhibitor |
| 09/10/2003 | CN1440973A Optical pure analog of camptothecine |
| 09/10/2003 | CN1440972A Optical pure synthetic intermediate of camptothecine and its preparing method |
| 09/10/2003 | CN1440971A Vitronectin receptor antagnist, its preparation and use |
| 09/10/2003 | CN1440816A Improvement for diagnosis and/or therapeutic agnet and its relative improvement |
| 09/10/2003 | CN1440754A Medicine recipe and prepn process |
| 09/10/2003 | CN1440753A Children's brain-nourishing chewing gum |
| 09/10/2003 | CN1440752A Recipe and prepn process of cyclovirobuxine dripping pills |
| 09/10/2003 | CN1440751A Matrix metal proteinase and tumor necrosis inhibitor |
| 09/10/2003 | CN1440750A Delayed releasing kurarinol prepn |
| 09/10/2003 | CN1440749A Edaravone injection for treating acute cerebral thrombus and its prepn |
| 09/10/2003 | CN1440748A Water soluble anticancer medicine taxol composite and its prepn |
| 09/10/2003 | CN1440747A Application of chrysophanic acid and chrysophanate in preparing obesity treating medicine |
| 09/10/2003 | CN1440746A Terbinafine hydrochloride capsule |
| 09/10/2003 | CN1440745A Fluoxetine medicinal preparation |
| 09/10/2003 | CN1440744A Coated nano melatonin composite health tonic |
| 09/10/2003 | CN1120878C Method for coal liquefaction |
| 09/10/2003 | CN1120848C Derivative of lentinan monomer and its preparing process and application |
| 09/10/2003 | CN1120843C Isomerisation of equilin |
| 09/10/2003 | CN1120842C New thiazole benzimidazole derivative |
| 09/10/2003 | CN1120841C Medicine composition and use thereof |
| 09/10/2003 | CN1120838C Dihydrobenzofuran compounds useful as anti-inflammatong agents |
| 09/10/2003 | CN1120832C Anti-tumour compound and its prepn. and pharmaceutical use |
| 09/10/2003 | CN1120745C Microcapsule containingt core material and its producing method |
| 09/10/2003 | CN1120722C External used paste for treating leukoderma, leukoplakia valvae and other vitiligines, and its preparing method |
| 09/10/2003 | CN1120721C External applied ointment for treating piles |
| 09/10/2003 | CN1120716C Plaster for curing bony spur and its preparing process |
| 09/10/2003 | CN1120708C Medicine prepared from bolostemmatoside B for preventing and curing tumor |
| 09/10/2003 | CN1120707C Ligands to enhance cellular uptake of biomolecules |
| 09/10/2003 | CN1120706C Use of ursonic acid in preparation of depression treatment medicine |
| 09/09/2003 | US6617463 Method for the production of L-ascorbic acid by lactonization of 2-keto-L-gulonic acid or s2-keto-L-gulonate esters |
| 09/09/2003 | US6617457 Hydrogenolysis of the benzyl ester of quinapril in an alcoholic solvent, with hydrochloric acid and hydrogenation; removal of the solvent; addition of toluene to precipitate the product as a solvate |
| 09/09/2003 | US6617452 Liquid-liquid extraction being carried out in the first stage at a pH-value of about 4; treating narrow-angle glaucoma, Alzheimer's disease, as well as alcohol and nicotine dependence. |
| 09/09/2003 | US6617450 P-glycoproteins and uses thereof |
| 09/09/2003 | US6617440 Isolated polynucleotide that promotes transcription; gene expression inhibition; used for engineering animals with increased lean meat and promoting muscle growth; treating muscular disorders |
| 09/09/2003 | US6617437 Modified oligonucleotide of given formula; useful in diagnostics and therapeutics |
| 09/09/2003 | US6617432 Useful as markers in diagnosing, monitoring the stage of malignancy and treating prostate cancer |
| 09/09/2003 | US6617430 Ataxin-2 binding proteins |
| 09/09/2003 | US6617426 Peptide analogs of given formula; useful in treating neurodegenerative, autoimmune, cognitive disorders, stroke and traumatic injury |
| 09/09/2003 | US6617425 Of given formula; stable in solution and resistant to proteolytic degradation; use in drug formulations |
| 09/09/2003 | US6617361 Protocol for prevention of Alzheimer's disease involves stimulating implicit memory; psychotherapeutic or psychological supports; stimulating explicit memory; transfers learned behavior into the implicit memory. |
| 09/09/2003 | US6617360 Medical treatment |
| 09/09/2003 | US6617359 4-fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical |
| 09/09/2003 | US6617358 Also bis(optionally chloro- or fluoro-substitutedphenyl)alkylcarboxy acids and esters |
| 09/09/2003 | US6617357 Administering to a patient for inhibiting cyclic nucleotide phosphodiesterases (PDEs) activity, a benzenesulfonamide compound |
| 09/09/2003 | US6617356 Comprising a stable suspension of silicon dioxide in a number selected from the group consisting of food grade vegetable oils and mineral oils, and the carrier being in the form of pourable gel |
| 09/09/2003 | US6617355 Treating asthma by preventing and/or accomodating S-nitrosothiol breakdown |
| 09/09/2003 | US6617354 Method of stabilizing and potentiating the action of anti-angiogenic substances |
| 09/09/2003 | US6617353 Prostaglandin derivtives substituted with hydroxypropynyl and carboxyalkylthioalkyl groups, dispersed in a water-soluble polymer; used to treat sleep disorders |
| 09/09/2003 | US6617352 Compounds and methods for the inhibition of the expression of VCAM-1 |
| 09/09/2003 | US6617349 Blends of isoflavones and flavones |
| 09/09/2003 | US6617348 Treating or preventing osteoporosis |
| 09/09/2003 | US6617347 Selective β3 adrenergic agonists |
| 09/09/2003 | US6617346 Inhibit the interaction of MDM2 protein with a p53-like peptide and have antiproliferative activity |
| 09/09/2003 | US6617345 Cyclooxygenase-2 inhibitor is (5-bromo-2-(4-fluorophenyl )-3-(4-(methylsulfonyl)phey)-thiophene), N-(2-(cyclohexyloxy 4-nitrophenyl)-methanesulfonamide), meloxicam, flosulide or cyclic substituted phenyl sulfones or sulfonamides |
| 09/09/2003 | US6617344 Heterocyclically substituted benzoylguanidines, process for their preparation, their use as medicaments or diagnostics, and medicaments comprising them |
| 09/09/2003 | US6617339 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
| 09/09/2003 | US6617338 Condensation of omeprazole, lansoprazole or pantoprazole with an addition copolymer having acrylonitrile, acrylic ester or aromatic olefin monomers, to form the polymer conjugate; improved bioavailability |
| 09/09/2003 | US6617337 Use of nitroxides for the treatment of essential hypertension |
| 09/09/2003 | US6617336 Treatment of urinary incontinence, venous insufficiency, migraine or gastrointestinal disorders |
| 09/09/2003 | US6617333 Antineoplastic combinations comprising |
| 09/09/2003 | US6617332 Cyclic amidinourea derivatives |